| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/22/2009 | EP2050450A1 1-Piperidine-2-cyanoimino-1,3-dihydro-2H-benzimidazole derivatives as nociceptin analogs with ORL1 modulating activity for the treatment of pain |
| 04/22/2009 | EP2050449A1 Aqueous liquid preparation containing amide compound |
| 04/22/2009 | EP2050344A1 Fish feed |
| 04/22/2009 | EP2049664A1 Methods and means for treating dna repeat instability associated genetic disorders |
| 04/22/2009 | EP2049119A2 Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morphoolin-4-ylmethyl-1h-benzoimidazol-2-yl)-1h-1-pyrazol-4-yl]-urea |
| 04/22/2009 | EP2049099A1 Compositions and methods for the treatment of mucositis |
| 04/22/2009 | EP2003140A9 Galactose derivative, drug carrier and medicinal composition |
| 04/22/2009 | EP2002832A9 Composition containing lignan compound |
| 04/22/2009 | EP1835907B1 Medicaments for the treatment or prevention of fibrotic diseases |
| 04/22/2009 | EP1551865B1 Hybrid molecules of macrolides with steroidal/non-steroidal anti-inflammatory molecules |
| 04/22/2009 | EP1531874B1 Embolic particles |
| 04/22/2009 | EP1515704B1 Microcapsules for the delayed, controlled release of perindopril |
| 04/22/2009 | EP1507529B1 Combination comprising valsartan, amlodipine and hydrochlorothiazide |
| 04/22/2009 | EP1505974B1 Use of compounds that are effective as selective opiate receptor modulators |
| 04/22/2009 | EP1480630B1 Use of folates for producing a preparation suitable for preventing and treating inflammation and diseases associated with inflammation, especially for influencing the inflammation markers crp and saa |
| 04/22/2009 | EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 04/22/2009 | EP1285908B9 Substituted phenylpropionic acid derivatives |
| 04/22/2009 | EP1200455B1 Enzyme catalyzed therapeutic activation |
| 04/22/2009 | EP0959897B1 Method of regulating nitric oxide production |
| 04/22/2009 | CN101415817A Entrapped stem cells and uses thereof |
| 04/22/2009 | CN101415702A Hetero compound |
| 04/22/2009 | CN101415425A Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 04/22/2009 | CN101415422A Anti-cancer pharmaceutical composition |
| 04/22/2009 | CN101412758A Anti-ErbB2 antibodies |
| 04/22/2009 | CN101412744A Anti-angiogenic compositions and methods of use thereof |
| 04/22/2009 | CN101411857A Pharmaceutical composition for treating cerebroma and cerebral concussion, and preparation method thereof |
| 04/22/2009 | CN101411853A Health care medical pillow for strengthening brain and inducing resuscitation |
| 04/22/2009 | CN101411811A Pharmaceutical composition for clearing heat, purging fire, nourishing yin and engendering fluid |
| 04/22/2009 | CN101411712A 5-beta-sapogenin and pseudosapogenin derivatives and their use in the treatment of dementia |
| 04/22/2009 | CN100480387C GBS toxin receptor |
| 04/22/2009 | CN100480375C Human cord blood derived unrestricted somatic stem cells (USSC) |
| 04/22/2009 | CN100480264C Earthworm protein suppressing cancer cell accretion by road spectrum and coding sequence thereof |
| 04/22/2009 | CN100480259C Telomerase inhibitory peptides and uses thereof |
| 04/22/2009 | CN100480245C 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
| 04/22/2009 | CN100479860C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 04/21/2009 | US7521570 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
| 04/21/2009 | US7521569 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521454 2-butylamino-8-hydroxy-9-(6-methyl-3-pyridylmethyl)adenine; interferon inducing activity; antiviral, antiallergic agent; immune response modulator; hepatitis B and C, asthma, atopic dermatitis |
| 04/21/2009 | US7521453 e.g. 5-Bromo-2-(3-methylisoxazol-5-ylmethylamino)-4-(5-cyclopropyl- 1H-pyrazol-3-ylamino)pyrimidine; anticarcinogenic, antitumor agents; breast, prostate, colon cancer |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521215 Polynucleotides, expression vectors, and host cells for culturing truncated tryptophanyl-tRNA synthetase polypeptides having chemokine activity; bioassay; drug screening; antitumor agents, antimetastasis agents |
| 04/21/2009 | US7521212 Method for producing oligopolysaccharides |
| 04/21/2009 | US7521206 Tumor necrosis factor (TNF); immunotherapy or diagnosis of TNF-related diseases such as cancer; nucleic acids, host cells, vectors |
| 04/21/2009 | US7521053 Angiopoietin-2 specific binding agents |
| 04/21/2009 | US7521042 Antihistamines, bronchodilator agents, antiinflammatory agents; mixture of drug and propellant |
| 04/21/2009 | US7521040 Immunotherapy for humans |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2228038C 2(1h)-quinolone derivatives, their preparation and their use in therapy |
| 04/21/2009 | CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation |
| 04/16/2009 | WO2009048936A1 Novel compounds as cannabinoid receptor ligands |
| 04/16/2009 | WO2009048532A2 Formation of particles for ultrasound application, drug release, and other uses, and microfluidic methods of preparation |
| 04/16/2009 | WO2009048148A1 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine |
| 04/16/2009 | WO2009048123A1 Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof |
| 04/16/2009 | WO2009048101A1 Amide compound |
| 04/16/2009 | WO2009047928A1 Method of producing functional dna, transformant and remedy for disease |
| 04/16/2009 | WO2009047903A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | WO2009047723A2 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders |
| 04/16/2009 | WO2009047644A2 Method of treating vitamin d insufficiency and deficiency |
| 04/16/2009 | WO2009047303A2 Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder |
| 04/16/2009 | WO2009047163A1 Methods of treating inflammatory diseases |
| 04/16/2009 | WO2009017646A3 Compositions comprising human collagen and human elastin and methods for soft tissue augmentation |
| 04/16/2009 | WO2008040002A9 Methods, compositions and articles of manufacture for hif modulating compounds |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | WO2005089426A3 Method of treating sepsis |
| 04/16/2009 | US20090099357 Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099258 Menthyl lactoyl lactate; impart a cooling and/or refreshing sensation to skin or mucous membranes and thereby improve the properties of foods, confections, cosmetics, medications, and other consumer goods;easy synthesis; cost efficiency |
| 04/16/2009 | US20090099241 Pharmaceutical composition containing antihypertensive agents |
| 04/16/2009 | US20090099238 Use of a ppar-alpha agonist to treat patients suffering from weight gain associated with a ppar-gamma agonist treatment |
| 04/16/2009 | US20090099202 External Preparation for Athlete's Foot Treatment |
| 04/16/2009 | US20090099193 Eml4-alk fusion gene |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090098229 Method of treating osteoporosis with extract of dioscorea sp. |
| 04/16/2009 | US20090098228 Agent and method for improvement of impairment of learning and memory |
| 04/16/2009 | US20090098220 Liquid pharmaceutical preparation comprising forskolin for promoting lean body mass |
| 04/16/2009 | US20090098195 Influenza virus infection suppressor |
| 04/16/2009 | US20090098191 Use of bases to stabilize transdermal formulations |
| 04/16/2009 | US20090098186 Method and system for coating a surface of a medical device with a therapeutic agent and drug eluting medical devices made thereby |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098131 Compositions and methods for the treatment of immune related diseases |
| 04/16/2009 | US20090098073 Phase change visual indicating composition |
| 04/16/2009 | US20090098053 La1 - the genome of a lactobacillus strain |
| 04/16/2009 | US20090095293 Dry powder inhalation system for transpulmonary administration |
| 04/16/2009 | US20090095289 Increased Dosage Metered Dose Inhaler |
| 04/16/2009 | DE202007017543U1 Mittel zur Raucherentwöhnung Means for smoking cessation |
| 04/16/2009 | CA2739719A1 Laminins, derivatives, and compositions including same and method for their therapeutic use |
| 04/16/2009 | CA2702171A1 Amide compound |
| 04/16/2009 | CA2702045A1 Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine |
| 04/16/2009 | CA2701880A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | CA2699504A1 Tetrahydroquinoline derivatives for treating post-traumatic stress disorders |
| 04/16/2009 | CA2683628A1 Method of treating vitamin d insufficiency and deficiency |
| 04/15/2009 | EP2048162A1 Novel monoclonal antibody and use of the same |
| 04/15/2009 | EP2048153A1 Substituted spiroketal derivative and use thereof as drug for treating diabetes |
| 04/15/2009 | EP2048152A1 Fused ring spiroketal derivative and use thereof as drug for treating diabetes |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2048145A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |